Production (Stage)
Bolt Biotherapeutics, Inc.
BOLT
$5.64
-$0.13-2.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.51% | 8.79% | 8.71% | 13.84% | 22.57% |
| Total Depreciation and Amortization | -6.67% | -3.94% | -1.46% | 0.99% | 3.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.46% | 10.49% | -6.70% | -12.92% | -31.48% |
| Change in Net Operating Assets | 60.87% | 14.44% | 53.15% | -77.58% | -34.70% |
| Cash from Operations | 7.91% | 11.85% | 16.51% | 8.59% | 16.82% |
| Capital Expenditure | 79.80% | 80.10% | 87.76% | 82.08% | 84.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.02% | -19.33% | -15.26% | -7.44% | 10.76% |
| Cash from Investing | 18.51% | -18.95% | -14.67% | -6.26% | 13.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -57.31% | -57.31% | -36.43% | -36.43% | -36.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -57.31% | -57.31% | -36.43% | -36.43% | -36.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 139.80% | -304.13% | 117.02% | 23.10% | 64.45% |